Their phytochemical analysis led to the isolation of a novel compound, 3,7-dihydroxy-5-methoxy-4,8-dimethyl-isocoumarin, which showed remarkable XO inhibition, suggesting a potential application in the treatment of hyperuricaemia comparable to conventional XO inhibitors such as allopurinol [70]. The gene discussed is XDH; the disease is hyperuricemia.